Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 6, 1999 - Issue 1
164
Views
76
CrossRef citations to date
0
Altmetric
Original Article

In vitro peroxidase oxidation induces stable dimers of β-amyloid (1-42) through dityrosine bridge formation

, , &
Pages 7-13 | Published online: 06 Jul 2009
 

Abstract

β-amyloid (Aβ) is a normal soluble peptide found in the cerebrospinal fluid (CSF) and other biological fluids. Aβ fibrils are associated with Alzheimer's disease (AD) senile plaques. We have used purified soluble Aβ (1-42) and Aβ (12-28) peptides in order to determine the oxidative modification induced in these peptides by exposure to peroxidase and hydrogen peroxide. We have demonstrated that under these in vitro conditions, dimeric forms of Aβ (1-42) can be detected by high-resolution polyacrylamide SDS-PAGE electrophoresis. Further experiments performed by reverse-phase high performance liquid chromatography (RP-HPLC), and monitored by fluorescence detection, showed that the dimeric Aβ (1-42) forms induced by the peroxidase reaction are the outcomes of dityrosine bridge formation. This cross-link results from the enzyme catalyzed oxidation. During this reaction, phenolic coupling of tyrosine residues of two Aβ (1-42) peptides occurs. No detectable peroxidative modifications were observed with the Aβ (12-28) peptide which lacks a tyrosine residue. Since oxidative stress is thought to be associated with AD, the experimental model described here can help in understanding the early events leading to chemical, structural and conformational modifications before the conversion of sAβ to amyloidfibrils and eventually the formation of senile plaques in AD.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.